Premium
Stakeboat Capital, a mid-market private equity firm backed and launched by serial healthcare entrepreneur GSK Velu, is reducing the size of its debut fund to mark its final close by March next year. The fund falling short of its target corpus echoes a trend identified in a VCCircle analysis earlier this ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
